← Human Trials & Peer-Reviewed Studies
Effects of exercise training intensity on nocturnal growth hormone secretion in obese adults with the metabolic syndrome.
Plain-language guide to PMID 19318453 (2009): randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 34 adults.
Key Facts
- PMID
- 19318453
- Journal
- The Journal of clinical endocrinology and metabolism
- Year
- 2009
- Study type
- Randomized Controlled Trial
- Authors
- Irving BA et al. (9 authors)
- DOI
- 10.1210/jc.2008-2256
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Their objective was to examine the effects of 16 wk endurance training on spontaneous 12-h overnight GH secretion in adults with the metabolic syndrome.
Why It Was Studied
However, little is known about the effects of endurance training intensity on spontaneous GH release in obese individuals.
Who Took Part
The study group was 34 adults.
PubMed indexes the participants as adults and middle-aged adults, both men and women.
A total of 34 adults with the metabolic syndrome (mean +/- sem: age: 49.1 +/- 1.8 yr) participated.
How the Study Was Run
The design is described as randomized.
The adults were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.
This randomized, controlled exercise intervention was conducted at the University of Virginia.
What Was Measured
PubMed files the paper under topics including Body Composition, Cardiovascular Physiological Phenomena, Circadian Rhythm, Exercise Therapy, Human Growth Hormone, Insulin-Like Growth Factor I and Metabolic Syndrome.
What This Means in Plain Language
The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 34 adults.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2009 (The Journal of clinical endocrinology and metabolism), a journal based in United States.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.